Company Filing History:
2 out of 1,974 
1 out of 3,539 
1 out of 5,450 
Years Active: 2007-2012
Title: Innovations by Alexander M DePaoli
Introduction
Alexander M DePaoli is a notable inventor based in Santa Barbara, California. He has made significant contributions to the field of medicine, particularly in the treatment of metabolic abnormalities associated with lipoatrophy. With a total of two patents to his name, DePaoli's work has the potential to impact many patients suffering from this condition.
Latest Patents
DePaoli's latest patents focus on the use of leptin, a hormone that plays a crucial role in regulating energy balance and metabolism. The first patent details the use of leptin, leptin analogs, and leptin derivatives to treat patients with lipoatrophy. This treatment is effective for both genetic and acquired forms of the disease. The patent outlines various methods of administration, including subcutaneous injections and gene therapy. The second patent emphasizes the use of leptin for treating human lipoatrophy and includes a method for determining predisposition to this treatment. Both patents highlight the importance of administering leptin to patients with a leptin level of approximately 4 ng/ml or less before treatment.
Career Highlights
Throughout his career, DePaoli has worked with prominent organizations such as Amgen Inc. and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His experience in these institutions has contributed to his expertise in the field of metabolic disorders and innovative treatments.
Collaborations
DePaoli has collaborated with esteemed colleagues, including Simeon I Taylor and Elif Arioglu Oral. These partnerships have likely enhanced his research and development efforts in the medical field.
Conclusion
Alexander M DePaoli is a distinguished inventor whose work on leptin and its applications in treating lipoatrophy showcases his commitment to advancing medical science. His contributions have the potential to improve the lives of many individuals affected by metabolic abnormalities.